fesoterodine

Known as: FESO, Propanoic acid, 2-methyl-, 2-((1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl Ester, fesoterodine [Chemical/Ingredient] 
A competitive muscarinic receptor antagonist with muscle relaxant and urinary antispasmodic properties. Fesoterodine is rapidly hydrolyzed in vivo… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2017
0102020052017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
OBJECTIVE To evaluate the cognitive effects of fesoterodine 4 and 8 mg versus placebo in healthy older adults. METHODS This was… (More)
Is this relevant?
2011
2011
OBJECTIVE • To show the superior efficacy of fesoterodine over tolterodine extended release (ER) in a placebo-controlled… (More)
Is this relevant?
2010
2010
OBJECTIVE To compare the efficacy and tolerability of fesoterodine 8 mg with tolterodine extended-release (ER) 4 mg and placebo… (More)
Is this relevant?
2009
2009
AIMS To evaluate the efficacy and tolerability of flexible-dose fesoterodine in subjects with overactive bladder (OAB) who were… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
OBJECTIVE Fesoterodine is a new antimuscarinic agent for the treatment of overactive bladder. Following oral administration… (More)
Is this relevant?
2008
2008
OBJECTIVES To compare the efficacy of fesoterodine 4 mg versus 8 mg in treating subjects with overactive bladder (OAB) syndrome… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2008
2008
OBJECTIVE To evaluate the effect of fesoterodine on health-related quality of life (HRQoL) in patients with overactive bladder… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2008
2008
OBJECTIVE To compare, in a post hoc analysis of a phase III trial, the maximum recommended doses of fesoterodine (8 mg) and… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE We evaluated the efficacy, tolerability and safety of the new antimuscarinic agent fesoterodine relative to placebo for… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To determine the efficacy, tolerability, and safety of fesoterodine in subjects with overactive bladder (OAB… (More)
Is this relevant?